Compare ClearPoint Neuro Inc (CLPT) vs General Mills, Inc. (GIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs General Mills, Inc. — how do they compare? ClearPoint Neuro Inc trades at $15.25 (market cap $462.44M), while General Mills, Inc. trades at $38.85 (market cap $20.38B). The key difference: General Mills, Inc. is far larger — about 44.1× ClearPoint Neuro Inc's market cap, and General Mills, Inc. pays a 6.39% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | GIS | |
|---|---|---|
Market Cap | $462.44M | $20.38B |
Sector | Health | Consumer Staples |
52-Week High | $29.60 | $51.11 |
52-Week Low | $8.66 | $32.17 |
Enterprise Value | $497.03M | $33.86B |
Dividend Yield | — | 6.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $15.18, up 1.88% today, with a bullish technical signal from moving averages. The stock shows strong revenue growth but deep losses, with a negative net income margin of -81.76% and a P/S ratio of 10.49. Recent news highlights regulatory progress with partners and expansion into focused ultrasound technology, though quarterly earnings have consistently missed expectations.
The outlook remains speculative with high growth potential in neuro-technology but significant execution risks. Analysts are unanimously bullish, citing long-term prospects, yet cash burn and missed earnings pose near-term challenges. Investment appeal hinges on successful commercialization and partnership milestones amid volatile financial performance.
General Mills (GIS) trades at $38.91, up 2.58% today, with a bullish technical signal and mixed earnings history including a recent Q2 2026 beat. The stock shows a low P/E of 9.23 but faces profitability challenges with a negative net income margin of -0.48% for 2026. Recent news highlights cost-saving initiatives and new product launches, while cash flow trends indicate modest net outflows in 2025.
The outlook is cautious; weak sales and margin pressure pose risks, but valuation and dividend yield near 5% offer value. Analysts are predominantly neutral with a consensus price target of $35.36, suggesting limited upside. Key risks include competitive pressures and debt levels, requiring careful monitoring of earnings recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Read more on GIS →
